EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Plasma Exchange in Thailand: A 10‐Year Retrospective Analysis

Kornchanok Vareesangthip iD, Areerat Ounhasuttiyanon, Kritsada Pongsakornkullachart, Kitilak Rochaikun, Jiraporn Jitprapaikulsan iD, Sasitorn Siritho, Parichart Permpikul, Adisorn Lumpaopong, Kriengsak Vareesangthip

Therapeutic Apheresis and Dialysis · 2026-08 · 30 (4) · 569-584

DOI: 10.1002/1744-9987.70148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 21.04.2026. Verfasst von Kornchanok Vareesangthip und 8 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Plasma Exchange. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Therapeutic plasma exchange (TPE) is a cornerstone of therapeutic apheresis across multiple subspecialties. While international registries have described global practice, nationwide data from Thailand are lacking.

Methods

We conducted a 10‐year retrospective analysis of all TPE admissions reimbursed under Thailand's Universal Health Coverage scheme (2014–2023). Cases were identified using ICD‐9 code 997.1. Demographics, clinical indications, complications, outcomes, and costs were extracted from discharge records. Indications were categorized according to the 2023 American Society for Apheresis (ASFA) guidelines.

Results

A total of 5884 admissions were identified. The mean age was 46.4 ± 20.6 years, 58.0% were male, and 13.0% were pediatric. TPE Utilization increased from the mid‐200s in 2014 to nearly 900 admissions in 2023. Neurological (28.9%) and nephrological (24.4%) disorders were the leading subspecialties. Systemic lupus erythematosus (12.4%), septic shock (12.1%), and acute inflammatory demyelinating polyradiculoneuropathy (9.1%) were the most frequent disease‐specific indications. Nearly three‐quarters of procedures were guideline‐supported (Category I: 28.6%, Category II: 31.7%), while Category III use was 28.1% in our cohort. In‐hospital mortality was 51.6% overall, driven largely by septic shock and acute liver failure, whereas survival exceeded 70% in autoimmune neurologic diseases and transplant recipients. Complications included bleeding (25.5%), transfusion requirements (69.0%), and hypocalcemia (9.7%). The actual cost per admission ranged USD 4000–12000, while reimbursement covered USD 2000–7000.

Conclusion

This first nationwide analysis of TPE in Thailand highlights increasing utilization, high‐cost burden, and important differences from global practice. Strengthening registries, refining coding systems, and developing region‐specific guidelines will be critical to optimize outcomes and sustainability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasma ExchangeHumansThailandRetrospective StudiesMaleFemaleMiddle AgedAdultAged

Stichwörter der Autor:innen

Thailandapheresisplasma exchange

Autor:innen und Institutionen

  • Renal Division, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Siriraj Neuroimmunology Center, Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Bumrungrad International Hospital, Bangkok, Thailand.
  • Department of Transfusion Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Division of Pediatric Nephrology, Department of Pediatrics, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.

ORCID-Profile: Kornchanok Vareesangthip, Jiraporn Jitprapaikulsan

Zitieren

APA

Vareesangthip, K., Ounhasuttiyanon, A., Pongsakornkullachart, K., Rochaikun, K., Jitprapaikulsan, J., Siritho, S., Permpikul, P., Lumpaopong, A., & Vareesangthip, K. (2026). Therapeutic Plasma Exchange in Thailand: A 10‐Year Retrospective Analysis. Therapeutic Apheresis and Dialysis, 30(4), 569-584. https://doi.org/10.1002/1744-9987.70148

Vancouver

Vareesangthip K, Ounhasuttiyanon A, Pongsakornkullachart K, Rochaikun K, Jitprapaikulsan J, Siritho S, et al. Therapeutic Plasma Exchange in Thailand: A 10‐Year Retrospective Analysis. Therapeutic Apheresis and Dialysis. 2026;30(4):569-584. doi:10.1002/1744-9987.70148

BibTeX
@article{Vareesangthip2026,
  author = {Vareesangthip, Kornchanok and Ounhasuttiyanon, Areerat and Pongsakornkullachart, Kritsada and Rochaikun, Kitilak and Jitprapaikulsan, Jiraporn and Siritho, Sasitorn and Permpikul, Parichart and Lumpaopong, Adisorn and Vareesangthip, Kriengsak},
  title = {Therapeutic Plasma Exchange in Thailand: A 10‐Year Retrospective Analysis},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2026},
  volume = {30},
  number = {4},
  pages = {569--584},
  doi = {10.1002/1744-9987.70148}
}
Kostenlos starten →